Department of Urology Publications 2021 Department of Urology academic productivity was at a high level in 2021 with nearly 70 papers, 21 chapters, 3 books and more than a dozen internet contributions. This does not include meeting abstracts and presentations that are presented on pages 26 through 28. Faculty and residents noted in bold.
Sanford T, Gomella PT, Siddiqui R, Su D, An JY, Bratslavsky G, Ball MW, Linehan WM, Metwalli AR. Long term outcomes for patients with von Hippel-Lindau and Pheochromocytoma: defining the role of active surveillance. Urol Oncol. 2021 Feb;39(2):134. e1-134.e8. doi: 10.1016/j.urolonc.2020.11.019. Epub 2020 Dec 8. PMID: 33303379.
Goldberg H, Noorani R, Benton JZ, Lodh A, Berlin A, Chandrasekar T, Wallis CJD, Ahmad AE, Klaassen Z, Fleshner NE. Is there an association between a history of military service and cancer diagnosis? Results from a US national-level study of self-reported outcomes. Cancer Causes Control. 2021 Jan;32(1):47-55.
Goldberg H, Mohsin FK, Berlin A, Chandrasekar T, Wallis CJD, Klaassen Z, Ahmad AE, Saskin R, Kenk M, Saarela O, Kulkarni GS, Alibhai SMH, Fleshner N. The suggested chemopreventive association of metformin with prostate cancer in diabetic patients. Urol Oncol. 2021 Mar; 39(3):191.e17191.e24. PMID: 32951988.
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscleinvasive bladder cancer: a single-arm, openlabel, repeat-dose clinical trial. Lancet Oncol. 2021 Jan;22(1):107-117. doi: 10.1016/S14702045(20)30540-4. Epub 2020 Nov 27. PMID: 33253641; PMCID: PMC7988888.
Chandrasekar T, Han TM, Glick L, Leong JY, Teplitsky S, Noorani R, Goldberg H, Klaassen Z, Wallis CJD, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG. Setting the Standards: Examining Research Productivity Among Academic Urologists in the USA and Canada in 2019. Eur Urol Focus. 2021 Mar;7(2):489496. PMID: 32113885.
Eisenbrey JR, Kamaya A, Gummadi S, Bird K, Burrowes D, Arias D, Lallas CD, Trabulsi EJ, Lyshchik A. Effects of Contrast-Enhanced Ultrasound of Indeterminate Renal Masses on Patient Clinical Management: Retrospective Analysis From 2 Institutions. J Ultrasound Med. 2021 Jan;40(1):131-139. PMID: 32657452. Shafi AA, McNair CM, McCann JJ, Alshalalfa M, Shostak A, Severson TM, Zhu Y, Bergman A, Gordon N, Mandigo AC, Chand SN, Gallagher P, Dylgjeri E, Laufer TS, Vasilevskaya IA, Schiewer MJ, Brunner M, Feng FY, Zwart W, Knudsen KE. The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. Nat Commun. 2021 Jan 15;12(1):401. doi: 10.1038/ s41467-020-20513-5. PMID: 33452241; PMCID: PMC7810852. Salib A, Mark JR. DNA analysis for prostate specimen verification: How I Do It. Can J Urol. 2021 Feb;28(1):10568-10573. PMID: 33625350. Teplitsky SL, Leong JY, Calio B, Hubosky SG, Bagley D. Ergonomics in Endourology: Measurement of Force for Deflection in Contemporary Ureteroscopes. J Endourol. 2021 Feb;35(2):215-220. PMID: 32993396. 72
Year in Review
Hoffman-Censits J, Choi W, Bivalacqua TJ, Pierorazio P, Kates M, Lombardo K, Parini V, McConkey D, Trabulsi EJ, Hahn N, Matoso A. Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience. Clin Genitourin Cancer. 2021 Apr;19(2):176-181. PMID: 33358150. Gómez Rivas J, Carrion DM, Chandrasekar T, Álvarez-Maestro M, Enikeev D, MartínezPiñeiro L, Barret E. The role of multiparametric magnetic resonance imaging in the selection and follow-up of patients undergoing active surveillance for prostate cancer. An European Section of Uro-Technology (ESUT) review. Actas Urol Esp (Engl Ed). 2021 Apr;45(3):188197. Ahdoot M, Lebastchi AH, Long L, Wilbur AR, Gomella PT, Mehralivand S, Daneshvar MA, Yerram NK, O'Connor LP, Wang AZ, Gurram S, Bloom J, Siddiqui MM, Linehan WM, Merino M, Choyke PL, Pinsky P, Parnes H, Shih JH, Turkbey B, Wood BJ, Pinto PA; Trio Study Group. Using Prostate Imaging-Reporting and Data System (PIRADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study. Eur Urol Oncol. 2021 Apr 10:S2588-9311(21)00048-1. doi: 10.1016/j. euo.2021.03.004. Epub ahead of print. PMID: 33846112.
Chandrasekar T, Ahmad AE, Sayyid R, Saarela O, Penn L, Alibhai SMH, Fleshner NE.. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer. Eur Urol Focus. 2021 May;7(3):537-545. Capella C, Godovchik J, Chandrasekar T, Al-Kouatly HB. Non-obstetrical roboticassisted laparoscopic surgery in pregnancy, an underutilized approach: a systematic literature review. Urology. 2021 May;151:58-66. Welti J, Sharp A, Brooks N, Yuan W, McNair C, Chand SN, Pal A, Figueiredo I, Riisnaes R, Gurel B, Rekowski J, Bogdan D, West W, Young B, Raja M, Prosser A, Lane J, Thomson S, Worthington J, Onions S, Shannon J, Paoletta S, Brown R, Smyth D, Harbottle GW, Gil VS, Miranda S, Crespo M, Ferreira A, Pereira R, Tunariu N, Carreira S, Neeb AJ, Ning J, Swain A, Taddei D; SU2C/PCF International Prostate Cancer Dream Team, Schiewer MJ, Knudsen KE, Pegg N, de Bono JS. Targeting the p300/CBP Axis in Lethal Prostate Cancer. Cancer Discov. 2021 May;11(5):1118-1137. doi: 10.1158/2159-8290.CD-20-0751. Epub 2021 Jan 11. PMID: 33431496; PMCID: PMC8102310. Capella C, Chandrasekar T, Counsilman MJ, Sebastiano C, Lallas CD, Al-Kouatly HB. Robotic adrenalectomy for functional adenoma in second trimester treats worsening hypertension. Urology. 2021 May;151: 67-71. Zhang Z, Lampotang S, Yu Y, Acar YA, Wakim J, Mei V, Ahmad AE, Shenot P, Lee J, Perlis N, Moy L, Johnson WT, DeStephens A, Bigos AK, Lizdas DE, Stringer T. Attitude is everything: Keep probe pitch neutral during side-fire prostate biopsy.A simulator study. BJU Int. 2021 May 7 Goldberg H, Glicksman R, Woon D, Hoffman A, Shaikh H, Chandrasekar T, Klaassen Z, Wallis CJD, Ahmad AE, Sanmamed-Salgado N, Qu X, Moraes FY, Diamandis EP, Berlin A, Fleshner NE. Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer? BJU Int. 2021 Jun;127(6):654-664. Shenot PJ. Rethinking the approach to evaluation and management of overactive bladder. Can J Urol. 2021 Jun;28(3):10705. PMID: 34129466.
Capella C, Schlegel L, Shenot P, Murphy A. Female Representation at High-profile Urology Conferences, 2014-2019: A Leadership Metric. Urology. 2021 Apr;150:72-76.
Goldberg H, Glicksman R, Hoffman A, Chandrasekar T, Klaassen Z, Wallis CJD, Ahmad AE, Woon DTS, Herrera-Caceres JO, Shaikh H, Salgado N, Qu M, Moraes FY, Diamandis E, Berlin A, Fleshner NE. “Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?” BJU Int. 2021 Jun;127(6):654-664.
Goldberg H, Mohsin FK, Saskin R, Kulkarni GS, Berlin A, Kenk M, Wallis CJD, Klaassen Z,
Ho M, Park BY, Rosenblum NG, Al Mukaddam M, Kaplan FS, Kucherov V, Hubosky SG, Kane
